We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ferring Pharmaceuticals the U.S. Food and Drug Administration (FDA) has approved Zomacton (somatropin) for injection in four additional pediatric indications:
Ferring Pharmaceuticals today announced thatFDA has approved ZOMACTON® for Injection 5 mg and 10 mg recombinant human growth hormone indicated for replacement of GH in adults with GH deficiency.